This is agreement with other studies in smooth muscle and cardiomyocytes where CaMKII activation in vivo under baseline physiological conditions is low, whereas pathological activation of CaMKII has been documented in numerous disease states, including diabetes and hypertension [8, 51]. The gene discussed is CAMK2G; the disease is Hypertension.